Figure 1: Pharmaceutical Market, France, Revenue ($B and €B), 2013-2020
Figure 2: Medical Devices Market, France, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in France, 2021
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Region
Figure 6: Country Profile, France, 2020
Figure 7: Pharmaceutical Market, France, Revenue ($B and €B), 2013-2020
Figure 8: Pharmaceutical Market, France, Revenue Forecast ($B and €B), 2021-2025
Figure 9: Pharmaceutical Exports ($B), France, 2013-2020
Figure 10: Top Export Partners, France, 2020
Figure 11: Pharmaceutical Imports ($B), France, 2013-2020
Figure 12: Top Import Partners, France, 2020
Figure 13: Pharmaceutical Supply Channel, France, 2019
Figure 14: % Share of Generics by Value, France, 2019
Figure 15: % Share of Generics by Volume, France, 2019
Figure 16: Marketing Authorizations (MA) for Generic Medicines, France, 2015-2019
Figure 17: Health Competitiveness Clusters, France, 2021
Figure 18: OTC Market, France, Revenue ($B), 2013-2020
Figure 19: OTC Market by Drug Category, France, Revenue ($M), 2020
Figure 20: Top Five Therapeutic Areas by Annual Revenue (%), France, 2019
Figure 21: COVID-19 Cases, France, 2020-2021
Figure 22: COVID-19 Deaths, France, 2020-2021
Figure 23: COVID-19 Fiscal Stimulus Timeline, France, 2020-2021
Figure 24: Vaccine Doses Administered per 1,000 People, France, 2021
Figure 25: COVID-19 Clinical Trials Count by Phase, France, 2020-2021
Figure 26: COVID-19 Clinical Trials Count by Trial Status, France, 2020-2021
Figure 27: Top Five COVID-19 Clinical Trials Sponsors by Trial Count, France, 2020-2021
Figure 28: Medical Devices Market, France, Revenue ($B), 2015-2020
Figure 29: Medical Devices Market, France, Revenue Forecast ($B), 2021-2025
Figure 30: Medical Device Market, France, Major Segments (%), 2020
Figure 31: General Surgery Market, France, Revenue ($B), 2017-2025
Figure 32: General Surgery Market, France, Market Share of Major Players (%), 2020
Figure 33: Cardiovascular Devices Market, France, Revenue ($B), 2017-2025
Figure 34: Cardiovascular Devices Market, France, Market Share of Major Players (%), 2020
Figure 35: Wound Care Management Market, France, Revenue ($B), 2017-2025
Figure 36: Wound Care Management Market, France, Market Share of Major Players (%), 2020
Figure 37: Orthopedic Devices Market, France, Revenue ($B), 2017-2025
Figure 38: Orthopedic Devices Market, France, Market Share of Major Players (%), 2020
Figure 39: Anesthesia and Respiratory Devices Market, France, Revenue ($B), 2017-2025
Figure 40: Anesthesia and Respiratory Devices Market, France, Market Share of Major Players (%), 2020
Figure 41: Diagnostics Market, France, Revenue ($B), 2015-2020
Figure 42: Diagnostics Market, France, Revenue Forecast ($B), 2021-2025
Figure 43: Medical Devices Market, Revenue ($B) of Major Companies, France, 2020
Figure 44: Deal Value and Deal Count, Pharmaceutical Market, France, 2020-2021
Figure 45: Deal Value and Deal Count Sub-types, Pharmaceutical Market, France, 2020-2021
Figure 46: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, France, 2020-2021
Figure 47: Top Five Therapy Areas by Deal Value and Deal Count, Pharmaceutical Market, France, 2020-2021
Figure 48: M&A Deals by Therapy Area, Pharmaceutical Market, France, 2020-2021 (by Value ($M) and by Number)
Figure 49: VC Deals by Therapy Area, Pharmaceutical Market, France, 2020-2021 (by Value ($M) and by Number)
Figure 50: PE Deals by Therapy Area, Pharmaceutical Market, France, 2020-2021 (by Value ($M) and by Number)
Figure 51: Medical Devices Market Deals by Deal Value ($M), France, 2020-2021
Figure 52: Medical Devices Market Deals by Deal Count, France, 2020-2021
Figure 53: Medical Devices Market Deals Share by Deal Value, France, 2020-2021
Figure 54: Medical Devices Market Deals Share by Deal Count, France, 2020-2021
Figure 55: Top Five Therapy Area by Deal Value ($M), Medical Devices Market, France, 2020-2021
Figure 56: Top Five Therapy Area by Deal Count, Medical Devices Market, France, 2020-2021
Figure 57: M&A Deals by Therapy Area, Medical Devices Market, France, 2020-2021 (by Value ($M) and by Number)
Figure 58: VC Deals by Therapy Area, Medical Devices Market, France, 2020-2021 (by Value ($M) and by Number)
Figure 59: Number of Products in Development and Marketed by French HealthTech and Purposes, France, 2020
Figure 60: Adoption of eHealth Technologies, France, 2020
Figure 61: Deal Value ($B), HealthTech, France, 2020-2021
Figure 62: Deal Count (No. of Deals), HealthTech, France, 2020-2021
Figure 63: Type of Products Developed by HealthTech Companies Against COVID-19, France, 2020
Figure 64: Health Innovation Coalition Projects, France, 2020
Figure 65: Organization of the Health System, France, 2020
Figure 66: Reimbursement of Medicinal Products, France, 2020
Figure 67: Reimbursement of Medical Devices, France, 2021
Figure 68: Share of Benefits Provided by Social Security, France, 2019
Figure 69: Share of Benefits in Medical Care and Goods, France, 2019
Figure 70: Share of Benefits Provided by State, Local and CMU-C Based Organizations, France, 2019
Figure 71: Share of Benefits Provided by Complementary Organizations , France, 2019
Figure 72: OOP Expenditure (% of Total Expenditure on Health), France, 2012-2020
Figure 73: Annual Rate of Change (%), Health Price Index, France, 2012-2020
Figure 74: The Evolution of the Price of Drugs, France, 2018
Figure 75:ANSM Organizational Structure, France, 2019
Figure 76: Marketing Authorization for Pharmaceutical Products, EU, 2020
Figure 77: Centralized Procedure, EU, 2021
Figure 78: Decentralized Procedure, EU, 2021
Figure 79: Mutual Recognition Procedure, EU, 2021
Figure 80: National Procedure, France, 2019
Figure 81: Conformity Assessment of Class I Medical Devices, EU, 2019
Figure 82: Conformity Assessment of Class IIa Medical Devices, EU, 2019
Figure 83: Conformity Assessment of Class IIb Medical Devices, EU, 2019
Figure 84: Conformity Assessment of Class III Medical Devices, EU, 2019
Figure 85: European Patent Approval Process, EU, 2020
Figure 86: Unitary Patent Approval Process, EU, 2020
Figure 87: Different Management Procedures for Category 1 Clinical Trials of Medicinal Products, France, 2021
Figure 88: Different Management Procedures for Category 1 Clinical Trials of Innovative Therapy Drugs, France, 2021
Figure 89: Different management procedures for Category 1 clinical trials of MD/IVD, France, 2021
Figure 90: Pharmaceutical Clinical Trials Count by Trial Status, France, 2020-2021
Figure 91: Pharmaceutical Clinical Trials Count by Therapy Area, France, 2020-2021
Figure 92: Pharmaceutical Clinical Trials Count by Phase, France, 2020-2021
Figure 93: Top Five Pharmaceutical Clinical Trial Sponsors by Count, France, 2020-2021
Figure 94: Medical Devices Clinical Trials Count by Trial Status, France, 2020-2021
Figure 95: Medical Devices Clinical Trials Count by Indication, France, 2020-2021
Figure 96: Medical Devices Clinical Trials Count by Category, France, 2020-2021
Figure 97: Top Five Medical Devices Clinical Trial Sponsors by Count, France, 2020-2021
Figure 98: Number of Hospitals, France, 2012-2018
Figure 99: Number of Diagnostic Equipment, France, 2015-2020
Figure 100: Hospital Beds (per 1,000 population), France, 2012-2018
Figure 101: Acute Care Hospital Beds (per 1,000 population), France, 2012-2018
Figure 102: Psychiatric Care Hospital Beds (per 1,000 population), France, 2012-2018
Figure 103: Life Expectancy at Birth (Years), France, 2012-2018
Figure 104: Immunization Rate (%), France, 2012-2019
Figure 105: Mean Population Exposure to PM2.5 (µg per m3), France, 2012-2019
Figure 106: CO2 Emissions (Million Tons), France, 2012-2019
Figure 107: Physicians (per 1,000 population), France, 2012-2018
Figure 108: Dentists (per 1,000 population), France, 2012-2018
Figure 109: Pharmacists (per 1,000 population), France, 2012-2018
Figure 110: Nurses (per 1,000 population), France, 2012-2018
Figure 111: Major Causes of Mortality (per 100,000 population), France, 2019
Figure 112: Major Causes of Male Mortality (per 100,000 population), France, 2019
Figure 113: Major Causes of Female Mortality (per 100,000 population), France, 2019
Figure 114: DALYs by Major Disease (per 100,000 population), France, 2019
Figure 115: Healthcare Expenditure as Percentage of GDP (%), France, 2012-2019
Figure 116: Health Expenditure Share (% of Total Health Spending), France, 2012-2019
Figure 117: Healthcare Expenditure Components by Function (% of Total Health Expenditure), France, 2018
Figure 118: Pharmaceutical Spending (% of Total Health Spending), France, 2012-2018